Clinical trial
Fecal Microbiota Transplantation for Eradication of Carbapenem-resistant Enterobacteriaceae Colonization: Prospective Interventional Non-comparative Study
NCT04790565 is registered in ClinicalTrials.gov with Rambam Health Care Campus as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Fecal Microbiota Transplantation for Eradication of Carbapenem-resistant Enterobacteriaceae Colonization: Prospective Interventional Non-comparative Study
- Lead sponsor
- Rambam Health Care Campus
- Phase
- Phase 2/3
- Overall status
- Completed
- Start date
- April 1, 2021
- Completion date
- October 1, 2022
- Enrollment
- 15 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
carbapenem-resistant enterobacteriaceae infection